OpenVSafe by OpenVAERS
Search V-safe

EPW-12049-77654

2 vaccinations 14 coded responses 29 check-ins 14 free-text entries 4 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
891 / NV
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Moderna
  3. 2021-01-14
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Fair
    Free text: Light-headed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea
    Free text: Lightheaded
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-01-21
    Survey response — day 7, dose 1
    MedDRA: Dizziness, Oral herpes — Feeling: Fair · Chills, Headache, Fatigue or tiredness
    Free text: Cold sore, light-headed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-28
    Survey response — day 14, dose 1
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Worsening headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-04
    Survey response — day 21, dose 1
    MedDRA: Headache, Migraine — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Persistent, worsening headaches/migraines
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-04
    Report sent to call center — day 21, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-11
    Survey response — day 28, dose 1
    MedDRA: Headache, Nausea, SARS-CoV-2 test negative, Vomiting — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Persistent and worsening headaches with nausea and vomiting.I have started my 2nd round of steroids and my doctor is wanting to admit me into the hospital for an IV infusion cocktail to break my headache cycle.I had a COVID PCR test = Not Detecte
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-11
    Report sent to call center — day 28, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-02-18
    Health check-in — day 35, dose 1
    Feeling: Fair
    Adult check-in
  15. 2021-02-25
    Health check-in — day 42, dose 1
    Feeling: Fair
    Adult check-in
  16. 2021-04-15
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  17. 2021-06-25
  18. 2021-06-29
  19. 2021-07-15
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  20. 2022-01-04
    Dose 2 — Moderna
  21. 2022-01-04
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  22. 2022-01-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  23. 2022-01-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  24. 2022-01-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  25. 2022-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Migraine, Self-medication — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Migraine - 1st day attempted no ibuprofen, started taking again
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Migraine, Self-medication — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Migraine - continue to take ibuprofen
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Migraine, Self-medication — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school
    Free text: Migraine - keep taking ibuprofen around the clock
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-01-11
    Survey response — day 7, dose 2
    MedDRA: Migraine — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school
    Free text: Migraine - doctor appointment tomorrow
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-01-18
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  30. 2022-01-25
    Survey response — day 21, dose 2
    MedDRA: Asthenia, Fatigue, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Continued headache/migraine with fatigue and weakness
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-25
    Report sent to call center — day 21, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-01-28
  33. 2022-01-28
    Call successful
    Participant prefers to complete VAERS report online
  34. 2022-02-01
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  35. 2022-02-08
    Survey response — day 35, dose 2
    MedDRA: Impaired work ability, Migraine — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Continued debilitating, constant migraine,. Still unable to return to work since my vaccine. Pending IV infusion treatment to break migraine since oral treatment of steroids didn't work.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-02-08
    Report sent to call center — day 35, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-02-10
    Call successful
    Does not wish to fill out VAERS report
  38. 2022-02-15
    Survey response — day 42, dose 2
    MedDRA: Epistaxis, Gastrointestinal disorder, Migraine, Paranasal sinus haemorrhage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Continued migraines - still waiting for insurance approval for IV treatment, GI/Digestion issues haven't resolved, started with sinus/nosebleed without congestion
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-07
    Survey response — 3 months, dose 2
    MedDRA: Gastrooesophageal reflux disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: GI - acid reflux
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-07-05
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  41. 2023-01-04
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Moderna
22022-01-04Moderna No

Call center

4 call center cases

4 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-14

Systemic reaction (other): Light-headed

Release 2 — days 1–6 daily, dose 1

2021-01-15

Systemic reaction (other): Lightheaded

Release 2 — day 7, dose 1

2021-01-21

Systemic reaction (other): Cold sore, light-headed

Release 2 — day 14, dose 1

2021-01-28

Symptoms: Worsening headaches

Release 3 — day 21, dose 1

2021-02-04

Symptoms: Persistent, worsening headaches/migraines

Release 4 — day 28, dose 1

2021-02-11

Symptoms: Persistent and worsening headaches with nausea and vomiting.I have started my 2nd round of steroids and my doctor is wanting to admit me into the hospital for an IV infusion cocktail to break my headache cycle.I had a COVID PCR test = Not Detecte

Release 10 — days 1–6 daily, dose 2

2022-01-08

Systemic reaction (other): Migraine - 1st day attempted no ibuprofen, started taking again

2022-01-09

Systemic reaction (other): Migraine - continue to take ibuprofen

2022-01-10

Systemic reaction (other): Migraine - keep taking ibuprofen around the clock

Release 10 — day 7, dose 2

2022-01-11

Systemic reaction (other): Migraine - doctor appointment tomorrow

Release 11 — day 21, dose 2

2022-01-25

Symptoms: Continued headache/migraine with fatigue and weakness

Release 11 — day 35, dose 2

2022-02-08

Symptoms: Continued debilitating, constant migraine,. Still unable to return to work since my vaccine. Pending IV infusion treatment to break migraine since oral treatment of steroids didn't work.

Release 11 — day 42, dose 2

2022-02-15

Symptoms: Continued migraines - still waiting for insurance approval for IV treatment, GI/Digestion issues haven't resolved, started with sinus/nosebleed without congestion

Release 11 — 3 months, dose 2

2022-04-07

Symptoms: GI - acid reflux

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia · · ✓
SDEpistaxis · · ✓
SDFatigue · · ✓
SDGastrointestinal disorder · · ✓
SDGastrooesophageal reflux disease · · ✓
SDHeadache ✓ ✓ ✓
SDImpaired work ability · · ✓
SDMigraine ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDParanasal sinus haemorrhage · · ✓
SDSARS-CoV-2 test negative ✓ ✓ ✓
SDVomiting ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROMigraine · · ✓
SROOral herpes ✓ ✓ ✓
SROSelf-medication · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release